Saturday 17 October 2026 Export JANX’s income statement to Excel — free account

Janux Therapeutics, Inc.

Janux Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.0 million, down 5.55% from fiscal 2024. In the quarter to June 2026, revenue grew 2,238.7%, EPS grew 36.4% and free cash flow grew 150.6%, each against the same quarter a year earlier.

16.49 0.83 −4.79%

Follow JANX

Alert me

Market cap: $1.1B
P/E: 0.0×
Fwd P/E: −7.8×
Dividend yield: —
F-score: 2/9
Altman Z: 11.61
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	—	0.00	+8 more quarters Free account
P/S ratio Full definition →	40.28	61.46	—	78.40
P/FCF ratio Full definition →	0.00	0.00	—	0.00
P/Operating CF Full definition →	77.44	(70.60)	—	(117.91)
P/B ratio Full definition →	1.04	0.93	—	1.55
Price to Tangible BV Full definition →	1.04	0.93	—	1.55
EV/Sales Full definition →	(0.17)	(6.02)	—	27.25
EV/EBITDA Full definition →	0.03	0.50	—	0.00
EV/Operating CF Full definition →	0.10	1.10	—	(7.48)
EV/FCF Full definition →	0.10	1.09	—	(7.38)
Quick Ratio Full definition →	16.14	16.83	38.67	35.54
Current Ratio Full definition →	16.35	17.01	39.04	35.86
Net Debt/EBITDA Full definition →	28.46	26.30	21.26	25.12
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.02	0.01	0.00	0.02
Operating CF/Net income Full definition →	(0.57)	0.51	0.89	0.53
Capex/Depreciation Full definition →	0.08	0.13	0.03	0.02
Research and Development Expense of Revenue Full definition →	301.88%	718.27%	0.00%	346.29%
Selling, General and Administrative Expense of Revenue Full definition →	106.78%	298.23%	0.00%	106.22%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	88.26%	248.30%	0.00%	90.44%
Graham Net Nets Full definition →	0.93	1.05	—	0.63
Graham Number Full definition →	0.00	0.00	—	0.00
Earnings Yield Full definition →	(10.68%)	(13.24%)	—	(6.87%)
Free Cash Flow Yield Full definition →	(4.34%)	(9.01%)	—	(4.71%)
Revenue per Share Full definition →	0.16	0.06	0.00	0.16
Operating CF per Share Full definition →	0.20	(0.20)	(0.46)	(0.21)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	0.20	(0.20)	(0.46)	(0.21)
Cash per Share Full definition →	15.43	15.26	15.60	15.95
Shareholders Equity per Share Full definition →	14.74	15.02	15.44	15.74
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	14.74	15.02	15.44	15.74
Free Cash Flow Full definition →	12.28	(12.61)	(28.65)	(12.95)
Working Capital Full definition →	923.19	943.13	950.89	970.26
Capital Expenditures Full definition →	(0.20)	(0.27)	(0.11)	(0.09)
Net Current Asset Value Full definition →	903.67	915.36	931.14	949.88
EV/EBIT Full definition →	0.03	0.54	—	0.00
Capex to Sales Full definition →	0.02	0.07	0.00	0.01
Price to Operating Income Full definition →	0.00	0.00	—	0.00
Other line items
Average Receivables Full definition →	0.92	18.25	—	—
Average Payables Full definition →	3.25	2.86	4.50	2.93
Average Assets Full definition →	1,019.93	1,039.50	1,031.54	859.89
Average Common Equity Full definition →	959.25	977.00	989.80	816.33

Fold the line items

Columns are period end dates

Stockrow Weekly